Biotech Boom: Stocks Skyrocketing & What's Next Hosted by Laycee KluinMarch 5, 2024 ShareLink copied to clipboard. Play video for Biotech Boom: Stocks Skyrocketing & What's NextDetailsGuestsFrom the surging trend in weight loss megatrends to the innovative strides in smart chemotherapy, Dylan Jovine from Behind The Markets breaks down the shifts he's observed. We delve into the burgeoning weight loss market led by giants like Eli Lilly and Novo Nordisk, and the strategic acquisitions by big pharma to incorporate breakthrough weight loss drugs into their portfolios. Dylan also shares his golden rules for evaluating biotech stocks, emphasizing the importance of late-stage companies, strategic partnerships, and experienced management. Furthermore, we explore the emerging areas within biotech, notably the revolutionary smart chemo, and discuss the financial health and future prospects of biotech companies. Despite the risks and challenges facing the industry, including a shortfall in private funding, Dylan's insights provide valuable guidance for investors navigating this rapidly evolving sector.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioLLYEli Lilly and Company4.9985 of 5 stars$672.50+1.8%0.89%43.90NVONovo Nordisk A/S4.6955 of 5 stars$50.48-0.8%3.25%13.87IMGNImmunoGenN/A$31.23N/A-100.74GSKGSK2.6526 of 5 stars$38.79-0.9%4.41%17.96BMYBristol Myers Squibb4.6626 of 5 stars$47.40-0.9%5.23%19.11AZNAstraZeneca3.7033 of 5 stars$78.15+0.3%1.29%29.38IOVAIovance Biotherapeutics4.1521 of 5 stars$2.47+0.6%N/A-2.00 Compare These Stocks Add These Stocks to My Watchlist Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTesla is in troubleThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored Listen to MarketBeat Other Platforms Recent Videos Featured Articles and OffersTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyAugust 9, 2025Generate up to $5,000/month with 10X less money?From Investors Alley (Ad)3 AI Infrastructure Stocks Powering the Next Tech RevolutionAugust 8, 2025An Atomic Sized Surge Is Brewing for NuScale Power Stock PriceAugust 11, 2025IBM: The Last Time This Happened, the Stock Rallied 35%August 12, 2025Sell this, buy thatFrom InvestorPlace (Ad) Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Laycee KluinMarch 5, 2024 ShareLink copied to clipboard. Play video for Biotech Boom: Stocks Skyrocketing & What's NextDetailsGuestsFrom the surging trend in weight loss megatrends to the innovative strides in smart chemotherapy, Dylan Jovine from Behind The Markets breaks down the shifts he's observed. We delve into the burgeoning weight loss market led by giants like Eli Lilly and Novo Nordisk, and the strategic acquisitions by big pharma to incorporate breakthrough weight loss drugs into their portfolios. Dylan also shares his golden rules for evaluating biotech stocks, emphasizing the importance of late-stage companies, strategic partnerships, and experienced management. Furthermore, we explore the emerging areas within biotech, notably the revolutionary smart chemo, and discuss the financial health and future prospects of biotech companies. Despite the risks and challenges facing the industry, including a shortfall in private funding, Dylan's insights provide valuable guidance for investors navigating this rapidly evolving sector.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioLLYEli Lilly and Company4.9985 of 5 stars$672.50+1.8%0.89%43.90NVONovo Nordisk A/S4.6955 of 5 stars$50.48-0.8%3.25%13.87IMGNImmunoGenN/A$31.23N/A-100.74GSKGSK2.6526 of 5 stars$38.79-0.9%4.41%17.96BMYBristol Myers Squibb4.6626 of 5 stars$47.40-0.9%5.23%19.11AZNAstraZeneca3.7033 of 5 stars$78.15+0.3%1.29%29.38IOVAIovance Biotherapeutics4.1521 of 5 stars$2.47+0.6%N/A-2.00 Compare These Stocks Add These Stocks to My Watchlist Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTesla is in troubleThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored
MarketBeat All Access